Clinical trial
Albumin and Crystalloid Administration in Septic Shock (ALCAMIST): Multi-center, Open Labelled Randomized Controlled Trial
NCT05148286 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Albumin and Crystalloid Administration in Septic Shock (ALCAMIST): Multi-center, Open Labelled Randomized Controlled Trial
- Lead sponsor
- Asan Medical Center
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- January 17, 2022
- Completion date
- December 31, 2027
- Enrollment
- 2,426 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
septic shock